Skip to main content
Download PDF

Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

Stem Cell Research & Therapy volume 12, Article number: 443 (2021) Cite this article

The Original Article was published on 29 March 2021

Correction to: Stem Cell Research & Therapy (2021) 12:217 https://doi.org/10.1186/s13287-021-02283-z

The original article contained an error whereby Affiliation #5 was presented incorrectly. This has since been corrected.

Reference

  1. Marofi F, et al. Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism. Stem Cell Res Ther. 2021;12:217. https://doi.org/10.1186/s13287-021-02283-z.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

    Faroogh Marofi

  2. Department of Immunology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

    Safa Tahmasebi

  3. Department of Physiology, College of Medicine, University of Suleimanyah, Sulaymaniyah, Iraq

    Heshu Sulaiman Rahman

  4. Director of Research Institute “MitoKey”, Moscow State Medical University, Moscow, Russian Federation

    Denis Kaigorodov

  5. Tyumen State Medical University, Tyumen, Russian Federation

    Alexander Markov

  6. Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Trubetskaya St., 8-2, Moscow, Russian Federation, 119991

    Alexei Valerievich Yumashev

  7. Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

    Navid Shomali

  8. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

    Navid Shomali

  9. DigiCare Behavioral Research, Casa Grande, AZ, USA

    Max Stanley Chartrand

  10. Faculty Affairs, Taneja College of Pharmacy, University of South Florida, Tampa, FL, USA

    Yashwant Pathak

  11. Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia

    Yashwant Pathak

  12. Bone Marrow Transplant Center, Hiwa Cancer Hospital, Suleimanyah, Iraq

    Rebar N. Mohammed

  13. Toxicology and Chemotherapy Unit (G401), German Cancer Research Center, 69120, Heidelberg, Germany

    Mostafa Jarahian

  14. Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

    Roza Motavalli

  15. Department of Virology, Pasteur Institute of Iran, Tehran, Iran

    Farhad Motavalli Khiavi

Authors
  1. Faroogh Marofi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Safa Tahmasebi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Heshu Sulaiman Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Denis Kaigorodov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexander Markov
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alexei Valerievich Yumashev
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Navid Shomali
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Max Stanley Chartrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yashwant Pathak
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Rebar N. Mohammed
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Mostafa Jarahian
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Roza Motavalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Farhad Motavalli Khiavi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Roza Motavalli or Farhad Motavalli Khiavi.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Marofi, F., Tahmasebi, S., Rahman, H.S. et al. Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism. Stem Cell Res Ther 12, 443 (2021). https://doi.org/10.1186/s13287-021-02523-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13287-021-02523-2

Stem Cell Research & Therapy

ISSN: 1757-6512